Form 4: VolitionRx Executive Gael Forterre Reports Tax Withholding Transaction
SEC Form 4 Filing
Gael Forterre, Chief Commercial Officer of VolitionRx, reports a transaction involving the withholding of shares to cover tax obligations related to restricted stock units.
Summary
- Gael Forterre, the Chief Commercial Officer of VolitionRx Ltd, filed a Form 4 on October 8, 2024, reporting changes in beneficial ownership of the company's stock.
- On October 4, 2024, 5,433 shares of common stock were withheld by VolitionRx to cover tax obligations related to the settlement of 15,333 restricted stock units at a price of $0.883 per share.
- Following the transaction, Forterre directly owns 152,353 shares of VolitionRx common stock.
- Forterre also indirectly owns 5,000 shares through his spouse and 32,500 shares through Armorica Partners, LLC, where he is the managing director and sole shareholder.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to tax obligations, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax withholding procedure related to equity compensation.
Key Dates
| Date | Description |
|---|---|
| 10/04/2024 | Date of transaction where shares were withheld for tax obligations. |
| 10/08/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.